White Paper | ACOG – Screening for Chromosomal Abnormalities
Home » Archives for Dan Simkins » Page 2 Screening for Fetal Chromosomal Abnormalities Prenatal testing for chromosomal abnormalities is designed to provide an accurate assessment of a patient’s risk of carrying a fetus with a chromosomal disorder. A wide variety of prenatal screening and diagnostic tests are available; each offers varying levels of information
White Paper | ACOG – Screening for Chromosomal Abnormalities Read More »
White Paper | Considerations When Ordering Non-invasive Prenatal Screening (NIPS)
Home » Archives for Dan Simkins » Page 2 Considerations When Ordering Non-invasive Prenatal Screening (NIPS) NIPS generally relies on blood testing from the mother to reveal information from circulating cell-free DNA (cfDNA) from the placenta, which can be identified in the maternal plasma from five weeks after conception. CfDNA is released into the blood
White Paper | Considerations When Ordering Non-invasive Prenatal Screening (NIPS) Read More »
White Paper | Whole-Genome Sequencing Provides the Most Informative Noninvasive Prenatal Testing Results
Home » Archives for Dan Simkins » Page 2 Whole-Genome Sequencing Provides the Most Informative Noninvasive Prenatal Testing Results A comparative analysis of commercially available methods for noninvasive prenatal tests. Download PDF
SignatureDx – What We Do
Home » Archives for Dan Simkins » Page 2 SignatureDx Resources – What We Do One Pager Download PDF
Rooted in Research: NIPT and the Story of Dave Peters
Home » Archives for Dan Simkins » Page 2 Rooted in Research: NIPT and the Story of Dave Peters At SignatureDx, we’re driven to advance the field of early detection diagnostics through noninvasive technology. We uphold our core values in all aspects of our work, and our research collaborators share the SignatureDx passion to help
Rooted in Research: NIPT and the Story of Dave Peters Read More »